ACTEON acquired by DENTRESSANGLE

The third LBO of Acteon marks a definitive strategic shift toward institutional global leadership, orchestrated by Bridgepoint Development Capital alongside Raise Investissement and Euro Private Equity. The strategic rationale for this transaction centers on an "innovation-acceleration" play, merging the group’s industry-leading technical operational depth in ultrasonics with the sponsor’s extensive international commercial infrastructure. This structural alignment provides the organization with the scientific talent and logistical hardware required to address the increasing complexity of the global digital dentistry market. This operation allows the group to execute a definitive structural expansion of its product suite, particularly through a renewed emphasis on research and development following several years of stabilization. By incorporating the sponsor’s strategic discipline, the group is now positioned to leverage its recognized leadership in high-frequency imaging to deepen its presence in high-stakes markets such as North America and Asia.

Acteon (formerly Satelec-Pierre Rolland), a Mérignac-based medical-dental equipment and consumables manufacturer, has finalized a LBO transaction. Led by Edmond de Rothschild Capital Partners (ERCP) through the special purpose vehicle Financière Noé, the private equity sponsor acquires a 51% controlling interest, while the management team rolls over its equity to retain a 49% stake. Historical shareholders IDI, Edmond de Rothschild Investment Partners (ERIP), and mezzanine provider ICG are converting their stakes into the new structure, facilitating the complete exits of ABN Amro and XAnge Capital. The leveraged financing package comprises a senior debt facility structured across seven tranches and a mezzanine layer. Backed by its strong market positioning, the enterprise is well-placed to leverage its reconstituted investor base to accelerate its high-tech product pipeline and expand its global market presence.